DERMABOND
Total Payments
$1.9M
Transactions
2,899
Doctors
1,402
Companies
8
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $537,619 | 618 | 266 |
| 2023 | $460,979 | 770 | 417 |
| 2022 | $459,405 | 573 | 306 |
| 2021 | $473,254 | 938 | 556 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $1.8M | 973 | 92.2% |
| Food and Beverage | $53,484 | 1,299 | 2.8% |
| Education | $36,859 | 469 | 1.9% |
| Travel and Lodging | $36,271 | 150 | 1.9% |
| Unspecified | $16,720 | 1 | 0.9% |
| Space rental or facility fees (teaching hospital only) | $7,000 | 6 | 0.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $32.05 | 1 | 0.0% |
Payments by Type
General
$1.9M
2,898 transactions
Research
$16,720
1 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Investigation of a New Skin Closure Device Dermabond PRINEO for Total Shoulder Arthroplasty A Randomized Controlled Trial US | Ethicon Inc. | $16,720 | 0 |
Ad
Manufacturing Companies
- Medical Device Business Services, Inc. $1.2M
- Ethicon Inc. $354,683
- Ethicon US, LLC $319,888
- Ethicon Endo-Surgery Inc. $44,004
- DePuy Synthes Sales Inc. $11,261
- DePuy Synthes Products, Inc. $3,540
- Johnson and Johnson International $132.80
- Janssen Global Services, LLC $123.07
Product Information
- Type Device
- Total Payments $1.9M
- Total Doctors 1,402
- Transactions 2,899
About DERMABOND
DERMABOND is a device associated with $1.9M in payments to 1,402 healthcare providers, recorded across 2,899 transactions in the CMS Open Payments database. The primary manufacturer is Medical Device Business Services, Inc..
Payment data is available from 2021 to 2024. In 2024, $537,619 was paid across 618 transactions to 266 doctors.
The most common payment nature for DERMABOND is "Consulting Fee" ($1.8M, 92.2% of total).
DERMABOND is associated with 1 research study, including "Investigation of a New Skin Closure Device Dermabond PRINEO for Total Shoulder Arthroplasty A Randomized Controlled Trial US" ($16,720).